Risk Factors, Diagnosis, and Staging of Endometrial Cancer

  • Anupama Rajanbabu


Endometrial cancer is the seventh most common cancer in women worldwide and the fourth common cancer in women in developed countries [1]. The incidence of uterine cancer based on the US national database Surveillance, Epidemiology and End Results was 24.6/100,000 women [2]. The incidence of endometrial cancer though low in India as compared to developed countries is rising steadily possibly due to changes in lifestyle and urbanization [3, 4]. The age-adjusted rates (AARs) for uterine cancer is high in urban areas with Bangalore topping the list with 6.2/100,000 women. Thiruvananthapuram has an AAR of 5.7/100,000 followed by Delhi, Chennai, and Mumbai with AARs ranging from 4.1 to 4.4/100,000 women. The lowest incidences were noted from northeastern states and also from rural Ahmedabad and Maharashtra—AARs <1/100,000 [5].


Sentinel Lymph Node Endometrial Cancer Lynch Syndrome Endometrial Carcinoma National Comprehensive Cancer Network 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Boyle P, Levin B. World cancer report 2008. Lyon: WHO; 2008. p. 428.Google Scholar
  2. 2.
  3. 3.
    Yeole BB. Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India. Asian Pac J Cancer Prev. 2008;1:119–22.Google Scholar
  4. 4.
    Time trends in cancer incidence rates 1982–2010. Indian Council of Medical Research 2013. p. 93.Google Scholar
  5. 5.
    Three year report of population based cancer registries: 2009–2011. Indian Council of Medical Research 2013. p. 56.Google Scholar
  6. 6.
    Mahatshetty U, Aggarwal A, Ganesh B, et al. Clinical outcome of early-stage endometrioid adenocarcinoma a tertiary cancer center experience. Int J Gynecol Cancer. 2013;23(8):1446–52.CrossRefGoogle Scholar
  7. 7.
    Smith RA, von Echenbach AC, Wender R, et al. American cancer society guidelines for early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001—testing for early lung cancer detection. CA Cancer J Clin. 2001;51(1):38–75.CrossRefPubMedGoogle Scholar
  8. 8.
    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Davies C, Godwin J, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomized trials. Lancet. 2011;387:771.CrossRefGoogle Scholar
  9. 9.
    Unfer V, Casini ML, Costabile L, et al. Endometrial effects of long term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2004;82:145.CrossRefPubMedGoogle Scholar
  10. 10.
    Renehean AG, Tyson M, Eggar M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569.CrossRefGoogle Scholar
  11. 11.
    Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol. 2005;193:1640.CrossRefPubMedGoogle Scholar
  12. 12.
    Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180.CrossRefPubMedGoogle Scholar
  13. 13.
    Znagnolo V, Pasinetti B, Sartori E. Clinical review of 63 cases of sex cord stromal tumors. Eur J Gynaecol Oncol. 2004;25:431.Google Scholar
  14. 14.
    Lerner-Geva L, Rabinovici J, Lunenfeld B. Ovarian stimulation: is there a long-term risk for ovarian, breast and endometrial cancer? Womens Health (Lond Engl). 2010;6:831.CrossRefGoogle Scholar
  15. 15.
    Parazzini F, Pelucchi C, Talamini R, et al. Use of fertility drugs and risk of endometrial cancer in an Italian case–control study. Eur J Cancer Prev. 2010;19:428.CrossRefPubMedGoogle Scholar
  16. 16.
    Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskilid A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer. 2008;98:1582.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res. 2003;35:694.CrossRefPubMedGoogle Scholar
  18. 18.
    Session DR, Kalli KR, Tummon IS, et al. Treatment of atypical endometrial hyperplasia with an insulin sensitizing agent. Gynecol Endocrinol. 2003;17:405.CrossRefPubMedGoogle Scholar
  19. 19.
    Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31(20):2607–18.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Bjørge T, Engeland A, Tretli S, et al. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer. 2007;120:378–83.CrossRefPubMedGoogle Scholar
  21. 21.
    McCullough ML, Patel AV, Patel R, et al. Body mass and endometrial cancer risk by hormone re- placement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev. 2008;17(73–79):10.Google Scholar
  22. 22.
    American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106:413.CrossRefGoogle Scholar
  23. 23.
    Seebacher V, Schmid M, Polterauer S, et al. The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study. BMC Cancer. 2009;9:460.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Kavak Z, Ceyhan N, Pekin S. Combination of vaginal ultrasonography and pipelle sampling in the diagnosis of endometrial disease. Aust N Z J Obstet Gynaecol. 1996;36(1):63–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Zerbe MJ, Zhang J, Bristow RE, Grumbine FC, Abularach S, Montz FJ. Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. Gynecol Oncol. 2000;79:55–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Kudela M, Pilka R. Is there a real risk in patients with endometrial carcinoma undergoing diagnostic hysteroscopy (HSC)? Eur J Gynaecol Oncol. 2001;22:342–4.PubMedGoogle Scholar
  27. 27.
    Cicinelli E, Tinelli R, Colafiglio G, et al. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study. Menopause. 2010;17:511–5.PubMedGoogle Scholar
  28. 28.
    Soucie JE, Chu PA, Ross S, Snodgrass T, Wood SL. The risk of diagnostic hysteroscopy in women with endometrial cancer. Am J Obstet Gynecol. 2012;207:71.e1–5.CrossRefGoogle Scholar
  29. 29.
    Chang YN, Zhang Y, Wang YJ, Wang LP, Duan H. The effect of hysteroscopy on the peritoneal dissemination of endometrial cancer: a meta-analysis. Fertil Steril. 2011;96:957–61.CrossRefPubMedGoogle Scholar
  30. 30.
    The National Comprehensive Cancer Network Guidelines. Uterine neoplasms. 2014. Available at: Retrieved 16 June 2014.
  31. 31.
    Sood AK, Buller RE, Burger RA, Dawson JD, Sorosky JI, Berman M. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol. 1997;90:441–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Hsieh CH, ChangChien CC, Lin H, et al. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol. 2002;86:28.CrossRefPubMedGoogle Scholar
  33. 33.
    Barwick TD, Rockall AG, Barton DP, Sohaib SA. Imaging of endometrial adenocarcinoma. Clin Radiol. 2006;61(7):545–55.CrossRefPubMedGoogle Scholar
  34. 34.
    McComiskey MH, McCluggage WG, Grey A, et al. Diagnostic accuracy of magnetic resonance imaging in endometrial cancer. Int J Gynecol Cancer. 2012;22(6):1020–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Leisby S, Neerup L, Loft A, Kiil A, Costa J, Tabor A, et al. Gynecologic oncology MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol. 2013;128(2):300–8.CrossRefGoogle Scholar
  36. 36.
    Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer. 1987;60:2035.CrossRefPubMedGoogle Scholar
  37. 37.
    Mikuta JJ. International federation of gynecology and obstetrics staging of endometrial cancer 1988. Cancer. 1993;71(4 Suppl):1460–3.CrossRefPubMedGoogle Scholar
  38. 38.
    Creasman W. Revised FIGO staging carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105:109.CrossRefPubMedGoogle Scholar
  39. 39.
    American Joint Committee on Cancer. Corpus uteri, AJCC staging manual. 7th ed. New York: Springer; 2010. p. 403.Google Scholar
  40. 40.
    Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, Wright JD. Comparative performance of the 2009 international federation of gynecology and obstetrics’ staging system for uterine corpus cancer. Obstet Gynecol. 2010;116(5):1141–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Abu-Rustum NR, Iasonos A, Zhou Q, et al. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol. 2008;198(4):457.e1–5; discussion 457.e5–6.CrossRefGoogle Scholar
  42. 42.
    AlHilli MM, Mariani A. The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol. 2013;18(2):193–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Childers JM, Brzechffa PR, Hatch KD, Surwit EA. Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol Oncol. 1993;51:33–8. 18.CrossRefPubMedGoogle Scholar
  44. 44.
    Homesley HD, Boike G, Spiegel GW. Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a Gynecologic Oncology Group study. Int J Gynecol Cancer. 2004;14:341–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Kohler C, Klemm P, Schau A, Possover M, Krause N, Tozzi R, et al. Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies. Gynecol Oncol. 2004;95:52–61.CrossRefPubMedGoogle Scholar
  46. 46.
    Gemignani ML, Curtin JP, Zelmanovich J, Patel DA, Venkatraman E, Barakat RR. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol Oncol. 1999;73:5–11.CrossRefPubMedGoogle Scholar
  47. 47.
    Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma. Cancer. 2001;91:378–87.CrossRefPubMedGoogle Scholar
  48. 48.
    Eltabbakh GH. Analysis of survival after laparoscopy in women with endometrial carcinoma. Cancer. 2002;95:1894–901.CrossRefPubMedGoogle Scholar
  49. 49.
    Magrina JF, Weaver AL. Laparoscopic treatment of endometrial cancer: five-year recurrence and survival rates. Eur J Gynaecol Oncol. 2004;25:439–41. 28.PubMedGoogle Scholar
  50. 50.
    Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group study LAP2. J Clin Oncol. 2009;27:5331–6. 31.PubMedCentralCrossRefPubMedGoogle Scholar
  51. 51.
    Kornblith AB, Huang HQ, Walker JL, Spirtos NM, Rotmensch J, Cella D. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27:5337–42.PubMedCentralCrossRefPubMedGoogle Scholar
  52. 52.
    Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study. J Clin Oncol. 2012;30:695–700.PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Seamon LG, Cohn DE, Henretta MS, Kim KH, Carlson MJ, Phillips GS, et al. Minimally invasive comprehensive surgical staging for endometrial cancer: robotics or laparoscopy? Gynecol Oncol. 2009;113:36–41.CrossRefPubMedGoogle Scholar
  54. 54.
    Leitao Jr MM, Briscoe G, Santos K, Winder A, Jewell EL, Hoskins WJ, et al. Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach. Gynecol Oncol. 2012;125:394–9.CrossRefPubMedGoogle Scholar
  55. 55.
    Chan JK, Urban R, Cheung MK, et al. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer. 2007;109(12):2454–60.CrossRefPubMedGoogle Scholar
  56. 56.
    Bakkum-Gamez JN, Mariani A, Dowdy SC, et al. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol. 2011;123(1):58–64.CrossRefPubMedGoogle Scholar
  57. 57.
    Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23:3668–75.CrossRefPubMedGoogle Scholar
  58. 58.
    Lutman CV, Havrilesky LJ, Cragun JM, et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol. 2006;102(1):92–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Cormier B, Sauthier P, Lussier C, Zang G, Mayrand MH. Determinants of lymph node count in endometrial cancer surgical staging. Int J Gynecol Cancer. 2012;22(8):1361–6.CrossRefPubMedGoogle Scholar
  60. 60.
    Vidal F, Rafii A. Lymph node assessment in endometrial cancer: towards personalized medicine. Obstet Gynecol Int. 2013;2013:892465.PubMedCentralCrossRefPubMedGoogle Scholar
  61. 61.
    Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin 3rd F, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56:29–33.CrossRefPubMedGoogle Scholar
  62. 62.
    Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–16. 42.CrossRefPubMedGoogle Scholar
  63. 63.
    ASTEC Study Group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.CrossRefGoogle Scholar
  64. 64.
    Sonoda Y. Surgical treatment for apparent early stage endometrial cancer. Obstet Gynecol Sci. 2014;57(1):1–10.PubMedCentralCrossRefPubMedGoogle Scholar
  65. 65.
    Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165–72.CrossRefPubMedGoogle Scholar
  66. 66.
    Mayromatis ID, Antonopoulos CN, Matsoukis IL, et al. Validity of intraoperative gross examination of myometrial invasion in patients with endometrial cancer: a meta analysis. Acta Obstet Gynecol Scand. 2012;91:779.CrossRefGoogle Scholar
  67. 67.
    Kumar S, Medeiros F, Dowdy SC, et al. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012;127:525.CrossRefPubMedGoogle Scholar
  68. 68.
    Leitao Jr MM, Kehoe S, Barakat RR, et al. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol. 2008;111:244.CrossRefPubMedGoogle Scholar
  69. 69.
    Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996;62:169–73.CrossRefPubMedGoogle Scholar
  70. 70.
    Ballester M, Dubernard G, Bats AS, Heitz D, Mathevet P, Marret H, et al. Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study. Ann Surg Oncol. 2012;19:3515–21.CrossRefPubMedGoogle Scholar
  71. 71.
    How J, Lau S, Press J, et al. Gynecologic oncology accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: a prospective study. Gynecol Oncol. 2012;127(2):332–7.CrossRefPubMedGoogle Scholar
  72. 72.
    Raimond E, Ballester M, Hudry D, Bendifallah S, Daraï E, Graesslin O, Coutant C. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol. 2014. doi: 10.1016/j.ygyno.2014.03.019.PubMedGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of Gynecological OncologyAmrita Institute of Medical Sciences and Research Centre, Amrita VishwavidyapeethamKochiIndia

Personalised recommendations